Different Doses of Naronapride vs. Placebo in Gastroparesis
Clinical trial NCT05621811 · COMPLETED
Trial details
- NCT number
- NCT05621811
- Sponsor
- Dr. Falk Pharma GmbH
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-01-03
- Primary completion
- 2025-08-12
- Enrollment
- 328
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.